Submitted by Yan Pan on Wed, 21/05/2025 - 17:09
Four Cambridge biomedical and health researchers are among those announced today as newly-elected Fellows of the Academy of Medical Sciences, including Professor Clare Bryant at the Departments of Medicine and Veterinary Medicine.
The new Fellows have been recognised for their remarkable contributions to advancing medical science, groundbreaking research discoveries and translating developments into benefits for patients and the wider public. Their work exemplifies the Academy’s mission to create an open and progressive research sector that improves health for everyone.
They join an esteemed Fellowship of 1,450 researchers who are at the heart of the Academy’s work, which includes nurturing the next generation of scientists and shaping research and health policy in the UK and worldwide.
One of Cambridge’s new Fellows, Clare Bryant is Professor of Innate Immunity. She studies innate immune cell signalling during bacterial infection to answer fundamental questions about host-pathogen interactions and to search for new drugs to modify them. She also applies these approaches to study inflammatory signalling in chronic diseases of humans and animals. Clare has extensive collaborations with many pharmaceutical companies, is on the scientific advisory board of several biotech companies, and helped found the natural product company Polypharmakos. Clare is a Fellow of Queens’ College, Cambridge.
Also elected to the Academy of Medical Sciences Fellowship are:
- Professor Sam Behjati, Wellcome Sanger Institute & Addenbrooke's Hospital, Cambridge
- Professor Frank Reimann, Institute of Metabolic Science-Metabolic Research Laboratories
- Professor Mina Ryten, UK Dementia Research Institute
Professor Andrew Morris CBE FRSE PMedSci, President of the Academy of Medical Sciences, said: “The breadth of disciplines represented in this year’s cohort – from mental health and infectious disease to cancer biology and respiratory medicine – reflects the rich diversity of medical science today. Their election comes at a crucial time when scientific excellence and collaboration across disciplines are essential for addressing global health challenges both now and in the future. We look forward to working with them to advance biomedical research and create an environment where the best science can flourish for the benefit of people everywhere.”
The new Fellows will be formally admitted to the Academy at a ceremony on Wednesday 9 July 2025.
